Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02031549 · ClinicalTrials.gov registry record
Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation
A clinical trial, sponsored by Bruce Shapiro M.D..
- Completed
- Registry status
- 40
- Enrollment target
NCT02031549: Completed study, sponsored by Bruce Shapiro M.D..
NCT02031549 is a clinical trial that has completed, run by Bruce Shapiro M.D.. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02031549 has completed, sponsored by Bruce Shapiro M.D..
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
We will investigate potential correlation between SpermComet DNA fragmentation assay results and IVF cycle outcome.
Primary Outcome
The proportion of oocytes and of fertilized oocytes that form blastocysts.
Interventions
- OTHER SpermComet assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-04 |
What the finished NCT02031549 record still lists
NCT02031549 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SpermComet assay is the first listed.
NCT02031549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02031549 about?
NCT02031549 is a clinical study titled "Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation". We will investigate potential correlation between SpermComet DNA fragmentation assay results and IVF cycle outcome.
What is the current status of trial NCT02031549?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-01. Estimated completion is 2014-04.
What interventions are being tested in trial NCT02031549?
The interventions under investigation include: SpermComet assay (OTHER).
Who is sponsoring clinical trial NCT02031549?
This trial is sponsored by Bruce Shapiro M.D., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia